
|Articles|March 19, 2008
DEA exempts six anabolic steroid products from its regulatory control
The Drug Enforcement Administration is moving three anabolic steroid products out of Schedule III status.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
3
Pharmacists Are Essential Drivers of Opioid Stewardship Programs
4
Q&A: Pharmacists Help Patients Navigate Pneumococcal Vaccine Options
5






























